ALFA Filings
Every announcement, straight from the exchange
Every corporate announcement our alert engine sent, newest first: orders, results, earnings calls, fund raises, board meetings and more.
Announcement type
Time
108,046 announcements with these filters
Morepen Laboratories Ltd reported revenue from operations of ₹484.7 Cr (+4.0% YoY) and net profit of ₹15.7 Cr (-22.7% YoY) for Q4 FY26.
Brainbees (FirstCry) reports FY26 consolidated revenue of ₹85,479 Mn (+12% YoY) with Adjusted EBITDA rising 24% to ₹4,860 Mn. India Multichannel remains PAT and FCF positive.
Morepen Laboratories reported audited FY26 results and recommended a Rs. 0.20 per share final dividend. The board also revised the Medical Devices business transfer date.
Silicon Valley Infotech scheduled a board meeting for May 28, 2026, to approve audited financial results. The trading window remains closed until 48 hours post-declaration.
Angel Fibers scheduled a board meeting for May 30, 2026, to approve audited financial results. The trading window remains closed until June 1, 2026.
Rubfila International Ltd reported revenue from operations of ₹160.6 Cr (+8.9% YoY) and net profit of ₹6.4 Cr (-22.9% YoY) for Q4 FY26.
Black Box reported FY26 revenue of ₹6,322 Crore with order bookings crossing $1 Billion. The company declared a 50% dividend, reflecting strong operational momentum and growth visibility.
Rubfila International Ltd reported audited annual financial results for the period ended March 31, 2026. The Board also recommended a final dividend of Rs.2 per share.
RKD Agri & Retail Ltd rescheduled its board meeting from May 26 to May 28, 2026. The meeting will address regulatory matters at the registered office.
Amwill Health Care scheduled a board meeting for May 30, 2026. Directors will consider FY26 audited financial results and recommend a final dividend.
Salem Erode Investments Ltd reported revenue from operations of ₹0.7 Cr (-22.2% YoY) and a net loss of ₹1.4 Cr for Q4 FY26.
Salem Erode Investments reported its audited FY2026 financial results and re-appointed its internal and secretarial auditors. The board approved these outcomes during its May 2026 meeting.
Energy-Mission Machineries (India) Ltd reported revenue from operations of ₹85 Cr (+8.6% YoY) and net profit of ₹5.5 Cr (-11.3% YoY) for H2 FY26.
Procter & Gamble Health re-appointed Mr. S. Madhavan as Independent Director for five years starting November 2026. The move ensures leadership continuity and board stability.
Energy Mission Machineries reported consolidated annual total income of ₹161.49 Crore for FY26. The board approved audited results and related party transactions during the meeting.
Brainbees Solutions Ltd reported revenue from operations of ₹2,163 Cr (+12.0% YoY) and a net loss of ₹48.2 Cr for Q4 FY26.
Easy Trip Planners scheduled a board meeting on May 30, 2026, to approve audited financial results. This routine regulatory notice provides advance visibility for investors.
CMI Limited scheduled its 44th Committee of Creditors meeting on May 26, 2026. The session addresses general business matters under the ongoing insolvency resolution process.
Firstcry reported audited FY26 consolidated revenue of ₹8,547.94 Crore and approved further AED 34 Million investment in its subsidiaries. Results show significant year-on-year growth and ongoing global expansion.
Texmaco Rail & Engineering shareholders approved the Long Term Incentive Plan Scheme 2026 via postal ballot. The special resolution passed with a 95.97% majority vote.
Procter & Gamble Health reported FY26 sales of ₹1385 Crore and PAT of ₹327 Crore. The Board recommended a final dividend of ₹45 per share.
Innovative Ideals and Services (India) Ltd reported a net loss of ₹4.8 Cr for H2 FY26.
Innovative Ideals and Services (India) Ltd reported audited FY26 results with a qualified audit opinion. The company faces material uncertainty regarding its going concern status.
Mudunuru Ltd scheduled a board meeting on May 30, 2026. The board will consider audited financial results and the audit report for FY2026.
T & I Global Ltd scheduled a board meeting on May 30, 2026. Directors will consider and approve audited financial results for the 2026 fiscal year.
Croissance Ltd reported revenue from operations of ₹0.3 Cr and net profit of ₹0 Cr for Q4 FY26.
Pondy Oxides & Chemicals Ltd reported revenue from operations of ₹935.2 Cr (+78.6% YoY) and net profit of ₹37.5 Cr (+125.9% YoY) for Q4 FY26.
Easy Trip Planners approved a ₹319.63 Crore preferential share allotment to four entities. Simultaneously, it mutually terminated a Share Purchase Agreement with AB Finance Private Limited.
Croissance Ltd reported annual revenue of ₹0.81 Crore with a net profit of ₹0.05 Crore. The results received a qualified audit opinion due to unconfirmed balances.
Pondy Oxides & Chemicals reported consolidated annual total income of ₹2,964.00 Crore. The board also recommended a 100% dividend of ₹5.00 per share.